Page 9 of 10
OR7.1 | Metabolic Bone Disorders — Assignment
CLINICAL SCENARIO
This assignment develops your ability to integrate history, clinical examination, biochemical investigations, and radiological findings to differentiate the four major metabolic bone disorders (osteoporosis, osteomalacia, rickets, and Paget's disease), formulate a management plan, and communicate clinical reasoning in a structured written format. These skills are essential for managing common presentations in general and orthopaedic practice.
Instructions
- Read the clinical case provided below carefully.
- Identify the most likely metabolic bone disorder and justify your answer using history, examination findings, biochemistry, and radiology.
- Explain the underlying aetiopathogenesis of the disorder in this patient.
- Describe the relevant biochemical profile (Ca, PO4, ALP, vitamin D, PTH) expected in this condition and explain why each parameter is altered.
- Outline your immediate and long-term management plan, including pharmacotherapy, non-pharmacological measures, monitoring, and patient counselling.
- Identify one high-risk complication of this disorder and describe how you would prevent or manage it.
Case: Mrs P, a 64-year-old postmenopausal woman, presents to your clinic with a 6-month history of low back pain, fatigue, and generalised bone aching. She sustained a wrist fracture 8 months ago after a minor trip. She takes no medications, gets minimal sun exposure, and reports a poor dietary calcium intake. On examination, she has mild kyphosis and tenderness over the mid-thoracic spine. She is 155 cm tall; her GP notes she was 159 cm at age 40.
Investigations: Serum Ca 2.18 mmol/L (normal), PO4 0.72 mmol/L (low-normal), ALP 68 IU/L (normal), 25-OH Vitamin D 11 ng/mL (severely deficient), PTH 98 pg/mL (mildly elevated). DXA spine T-score: -2.9. X-ray spine: wedge compression fractures at T8 and T9.
Answer all five sections. Total word guidance: 600–900 words.
Length: 600–900 words
What to Submit
Diagnosis and Justification
Guidance: State your primary diagnosis and secondary contributing condition. Justify using at least three specific clinical, biochemical, or radiological features from the case. Distinguish from other metabolic bone diseases.
Aetiopathogenesis
Guidance: Explain the mechanisms in this patient: role of postmenopausal oestrogen deficiency, vitamin D insufficiency, secondary hyperparathyroidism, and impaired calcium absorption. Link these to the bone loss pattern seen.
Biochemical Profile Interpretation
Guidance: For each parameter (Ca, PO4, ALP, 25-OH VitD, PTH), state the expected value and mechanistic reason for each alteration in this patient's condition. Show you understand how these differ from osteomalacia and Paget's disease.
Management Plan
Guidance: Cover: (a) calcium and vitamin D supplementation with dosing rationale; (b) bisphosphonate therapy — agent, dose, route, instructions; (c) non-pharmacological measures (weight-bearing exercise, fall prevention, smoking/alcohol advice); (d) monitoring plan (DXA repeat, serum biochemistry); (e) patient counselling points.
High-risk Complication and Prevention
Guidance: Identify one serious complication (e.g. subsequent hip or vertebral fracture, progressive kyphosis and height loss, iatrogenic oesophageal ulceration from bisphosphonate). Explain how you would prevent it or manage it if it occurs.
Grading Rubric — Metabolic Bone Disorders Assignment Rubric
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| Accurate diagnosis and differential reasoning | 10 pts | Correctly identifies both osteoporosis and contributory vitamin D insufficiency; provides 3+ specific supporting features; clearly distinguishes from osteomalacia, Paget's disease, or other conditions with precise reasoning. |
| Mechanistic understanding of aetiopathogenesis | 10 pts | Clearly explains postmenopausal oestrogen loss causing osteoclast activation, vitamin D deficiency impairing calcium absorption, secondary PTH elevation, and net bone loss — all linked coherently to clinical and biochemical findings. |
| Biochemical profile interpretation | 10 pts | Correctly explains all five parameters (Ca, PO4, ALP, 25-OH VitD, PTH) with mechanistic reasons; accurately contrasts this profile with osteomalacia (raised ALP, low Ca/PO4) and Paget's disease (markedly raised ALP, normal Ca/PO4). |
| Comprehensive and accurate management plan | 10 pts | Complete plan covering calcium and vitamin D dosing with rationale, bisphosphonate choice with dose/route/correct administration instructions (empty stomach, remain upright 30 min), fall prevention, monitoring schedule, and tailored patient counselling. |
| Complication identification and prevention strategy | 10 pts | Identifies a clinically relevant high-risk complication (e.g., hip fracture, oesophageal ulceration from bisphosphonate, progressive kyphosis); provides a specific, evidence-based prevention or management strategy. |
PEER REVIEW
Evaluate your peer's submission using the 5 rubric criteria. For each criterion, select the most appropriate rating level and provide 2-3 sentences of specific written feedback: (1) what was done well, (2) what was missing or incorrect, and (3) one constructive suggestion for improvement. Be precise — refer to specific content, not just general comments. Your feedback should help your peer improve their clinical reasoning and written communication skills.